elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40459101-0DFE5F50-20E4-44CC-AE63-30BBA0C736A2
Q40459101-0DFE5F50-20E4-44CC-AE63-30BBA0C736A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40459101-0DFE5F50-20E4-44CC-AE63-30BBA0C736A2
Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer.
P2860
Q40459101-0DFE5F50-20E4-44CC-AE63-30BBA0C736A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40459101-0DFE5F50-20E4-44CC-AE63-30BBA0C736A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c548b092091ac912d2bb3cafec3bd73a1048ca8
P2860
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.